Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Hepatitis

Free Subscription 12.01.2026 2 BMC Gastroenterol 1 BMC Pediatr 1 Clin Infect Dis 1 Dig Dis Sci 1 Gut 2 J Med Virol 5 J Viral Hepat 1 JAMA 1 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. XIE Y, Zhang X, Yang X, Zheng S, et al
   HBV RNA at 6 months after nucleos(t)ide analogues treatment can predict antiviral efficacy in chronic hepatitis B patients.
   BMC Gastroenterol. 2026 Jan 2. doi: 10.1186/s12876-025-04579.
   PubMed         Abstract available
   
   
2. MA L, Zheng WW, Zhang Y, Wei W, et al
   Analysis of the incidence and risk factors of colorectal polyps in patients with chronic hepatitis B complicated by non - alcoholic fatty liver disease.
   BMC Gastroenterol. 2026 Jan 3. doi: 10.1186/s12876-025-04488.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

3. LIAO Y, Liu Y, Xu S, Yang J, et al
   Incomplete Kawasaki disease associated with acute icteric hepatitis and Torque teno virus infection: a case report and literature review.
   BMC Pediatr. 2026;26:14.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

4. HOFMEISTER MG, Symum H, Swanson BE, Barker LK, et al
   Estimated hepatitis C prevalence and viral clearance using residual sera from a large commercial laboratory-November 2023-September 2024.
   Clin Infect Dis. 2026 Jan 8:ciag007. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

5. KESER MF, Keser ZB, Yurdaydin C, Yilmaz S, et al
   Long-Term Post-transplant Outcomes in Patients with Hepatitis D Virus Infection at a High-Volume Liver Transplant Center.
   Dig Dis Sci. 2026 Jan 6. doi: 10.1007/s10620-025-09654.
   PubMed         Abstract available
   
   

   
   Gut

6. LIANG X, Luo J, Zhou Q, Xin J, et al
   Single-cell multimodal analysis reveals the dynamic immunopathogenesis of HBV-ACLF progression.
   Gut. 2026;75:367-381.
   PubMed         Abstract available
   
   

   
   J Med Virol

7. ZENG X, Liu H, Xu Z, Rao X, et al
   Analysis of Hepatitis B Virus Integration Reveals New Insights of Oncogenic Mechanism in Dysplastic Liver Nodule.
   J Med Virol. 2026;98:e70755.
   PubMed         Abstract available
   
   
8. ZENG X, Liu H, Xu Z, Rao X, et al
   Analysis of HBV Integration Reveals New Insights of Oncogenic Mechanism in Dysplastic Liver Nodule.
   J Med Virol. 2026;98:e70754.
   PubMed         Abstract available
   
   

   
   J Viral Hepat

9. TANG W, Ma Y, Du L, Bai L, et al
   Association Between Indirect Bilirubin Percentage to Albumin Ratio and Outcome of Hepatitis B Related Acute on Chronic Liver Failure Treated With Artificial Liver Support System.
   J Viral Hepat. 2026;33:e70131.
   PubMed         Abstract available
   
   
10. KATKURI SN, Vadhithala V, Kumar A, Verma S, et al
    Comments on "Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines".
    J Viral Hepat. 2026;33:e70132.
    PubMed        
    
    
11. KAMAL H, Jargalsaikhan G, Enkhtaivan S, Bruce D, et al
    Trends of Advanced Chronic Liver Disease Among 17,711 Persons in Mongolia During Years 2015-2023.
    J Viral Hepat. 2026;33:e70129.
    PubMed         Abstract available
    
    
12. BARAKAT EMF, Kohla M, Tawheed A, Shousha HI, et al
    Outcomes and Survival of Egyptian Patients With Hepatitis B-Related Hepatocellular Carcinoma: A Multicentre Retrospective Study.
    J Viral Hepat. 2026;33:e70127.
    PubMed         Abstract available
    
    
13. YIN S, Hofmeister MG, Thompson ND, Teshale EH, et al
    Characteristics of Newly Reported Chronic Hepatitis C Cases Among Adults in the United States, 2016-2023: Insights From Population-Based Surveillance.
    J Viral Hepat. 2026;33:e70123.
    PubMed         Abstract available
    
    

    
    JAMA

14. ROSE MR, Flexner C, Roy V
    Subscription-Based Pricing for Lenacapavir-Learning From Hepatitis C and Cabotegravir.
    JAMA. 2026 Jan 7. doi: 10.1001/jama.2025.24404.
    PubMed        
    
    

    
    Transplant Proc

15. SHANAHAN E, Hussaini T, Yoshida EM
    Evaluating the Use of Hepatitis B Immunoglobulin After Liver Transplant.
    Transplant Proc. 2026 Jan 3:S0041-1345(25)00584.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.